🚀 Chainlink ETF Speculation Heats Up – But Why Are Investors Dumping LINK?
Wall Street whispers of a Chainlink ETF hit fever pitch this week—just as LINK holders raced for the exits. The oracle network's token bled 12% despite the buzz, proving once again that crypto markets love nothing more than a good contradiction.
Analysts point to profit-taking after LINK's 90-day rally, but the timing reeks of classic 'buy the rumor, sell the news' behavior. Meanwhile, Grayscale's latest regulatory filing suggests institutional players might be laying groundwork for a crypto derivatives play that could include Chainlink.
As one trader quipped: 'Nothing makes hedge funds happier than retail investors panic-selling at the bottom.' The real question? Whether LINK's current $18 support level will hold when the ETF paperwork actually materializes.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
- Stellantis (STLA) stock fell after the automaker announced a recall for thousands of its vehicles.
- Microsoft (MSFT) stock gained after a top analyst initiated coverage of the shares.
- Cidara Therapeutics (CDTX) stock rocketed after the pharmaceutical company reached an agreement with Merck (MRK).
- Circle Internet (CRLC) stock was hit with a new street-low price target.
- Anavex Life Sciences (AVXL) stock took a beating after the clinical-stage biopharmaceutical company announced a regulatory update.
- Alphabet (GOOGL) stock slipped after the tech giant responded to a $3.4 billion fine from the European Union.
- SAP (SAP) stock sank after the software company agreed to make it easier for consumers to switch to rival platforms.
- Aspire Biopharma Holdings (ASBP) stock surged after the biotechnology company announced a new Equity Line of Credit (ELOC) agreement.
- Gauzy (GAUZ) stock was slammed after the smart glasses company delayed its Q3 results due to a French court case.
- Scholar Rock (SRRK) stock soared alongside an FDA meeting update in the company’s latest earnings report.
- The Dow Jones Industrial Average (DJIA) was down alongside ongoing economic struggles.
- CoreWeave (CRWV) stock was hit with a downgrade from a top analyst.
- Union Pacific (UNP) stock was up on a planned merger with Norfolk Southern (NSC).
- Valve’s Steam Machine will offer a “really competitive price” that could be a problem for Microsoft and Sony (SONY).
Read more of the top stock market stories on Friday.
